Official Website of The ICNA

Details
News
Hits: 588

icnc-lpJohn Stobo Prichard Award

The ICNA is now accepting applications for the John Stobo Prichard Award lecture. The lecture will be awarded to a young child neurologist who has made a significant contribution to clinical and/or basic research. The Nominating Committee consists of eighteen ICNA members representing the six geographic regions of the ICNA.

1. The candidate should be nominated by three members of the ICNA.

2. The candidate should be 45 years old or younger at the time of the ICNA congress in Iguazu, Brazil May 04-09 2014.

3. The nominating members should describe the candidate and his/her work and they should make clear why they consider the candidate’s work so relevant to the field of child neurology.

4. The candidate should be a child neurologist and an active member of the ICNA.

5. The nominating letter should be e-mailed to the Chairman of the Nominating Committee: This email address is being protected from spambots. You need JavaScript enabled to view it.

6. The deadline for nomination will be May 20, 2013.

7. From all the proposed names, the Nominating Committee will choose and rate the three most appropriate candidates in order of preference.

8. The candidates selected by the Nominating Committee will be proposed for final decision at the Executive Board meeting in Kaunas, May 28-29, 2013.

9. The award lecturer will be invited to present a lecture during a plenary session at the 2014 ICNA Congress in Brazil.

10. The successful candidate will receive $1000 towards travel to the congress, the costs of 3 nights’ accommodation (as selected by the committee) and the registration will be waived.

Sheila Wallace International Fellowship

The ICNA is now accepting applications for the Sheila Wallace International Fellowship Award which will sponsor $1000 towards travel to the congress, the costs of 3 nights’ accommodation (as selected by the committee) and the registration fee for a young Child Neurologist who has made a significant contribution to clinical research in his/her developing country to attend the 13th International Child Neurology Congress to be held in Iguazu, Brazil in 2014.

The Selection Committee consists of 18 members, of which three will come from each of the six ICNA geographic regions.

1. The candidate should be nominated by two members of the ICNA.

2. The candidate should be 45 years old or younger at the commencement of the ICNA congress in Iguazu, Brazil  May 04-09 2014.

3. The nominating members should describe the candidate and his/her work and they should make clear why they consider the candidate’s work so relevant to the field of child neurology.

4. The candidate should be a child neurologist and an active member of the ICNA, trained in an under-resourced country and practising child neurology in an academic setting.

5. The nominating letter should be e-mailed to the Chairman of the Nominating Committee: This email address is being protected from spambots. You need JavaScript enabled to view it.

6. The deadline for nomination will be May 20, 2013.

7. From all the proposed names, the Nominating Committee will choose and rate the three most appropriate candidates in order of preference.

8. The candidates selected by the Nominating Committee will be proposed for final decision at the Executive Board meeting in Kaunas, May 28-29, 2013.

9. The award lecturer will be invited to present a lecture in a plenary session at the 2014 ICNA Congress in Brazil.

Robert Ouvrier
Chairman,
Nominating Committee
International Child Neurology Association


Read More

Details
News
Hits: 526

838922 w2This is an invitation to submit an application to this program from the North American Commission of the ILAE. The program seeks to promote and improve the care of persons in Africa living with epilepsy, through education, advocacy and research. It aims specifically to support and expand exchange programs between members of the North American Commission and African chapters of the ILAE, in order to significantly impact epilepsy care in that region. Based on our experience with the Latin American and Caribbean partnerships, the ILAE is confident that NAC members can significantly contribute to this mission.

The application should address program goals. This program supports travel between North America and Africa to perform one and preferentially of the following activities:

1) Education and training of epileptologists, neurologists, neurosurgeons, primary care physicians, health care extenders, and/or other professionals involved in epilepsy care.

2) Education (and advocacy) of local authorities and opinion makers, to enhance community awareness of epilepsy, treatment gap, access to care, cultural and other issues that impact delivery of care.

3) Improve the provision of locally-sustainable patient care.

4) Initiate and foster sustainable collaborative research related to epilepsy.

The Education Task Force of the North American and African Commission will evaluate applications & support multiple partnerships in 2013. There is no honorarium designated for the faculty member. Reasonable travel and accommodation expenses will be covered up to the maximum of $5,000 (US dollars) per partnership. Applications to extend ongoing partnerships are accepted but priority will be given to new partnerships.

Deadline for reception for 2013 partnerships is May 31st 2013.

 Application Form


Read More

Details
News
Hits: 540
DEPDC5 mutationsResearchers from the Florey Neuroscience Institute in Melbourne, Victoria, Australia along with an international team of colleagues have published their discovery of the focal epilepsy gene in 31 March online issue of Nature Genetics1.
 
The majority of epilepsies are focal in origin, with seizures emanating from one brain region. Although focal epilepsies often arise from structural brain lesions, many affected individuals have normal brain imaging. The etiology is unknown in the majority of individuals, although genetic factors are increasingly recognized. Autosomal dominant familial focal epilepsy with variable foci (FFEVF) is notable because family members have seizures originating from different cortical regions.
 
Using exome sequencing, they detected mutations of the DEPDC5 gene in two affected families and subsequently identified mutations in five of six additional published large families with FFEVF. Study of families with focal epilepsy that were too small for conventional clinical diagnosis with FFEVF identified DEPDC5 mutations in approximately 12% of families (10/82). This high frequency establishes DEPDC5 mutations as a common cause of familial focal epilepsies. Shared homology with G protein signaling molecules and localization in human neurons suggest a role of DEPDC5 in neuronal signal transduction.
 
According to lead researcher, Professor Ingrid Scheffer at the Florey Neuroscience Institute in Melbourne, Victoria, Australia, this discovery is paradigm shifting, opening up new opportunities for diagnosing epilepsy.In the families studied, the researchers noted there were some individuals with intellectual disabilities, and some with autism spectrum disorders and psychiatric features.It is possible DEPDC5 may well play a role in these other disorders too, but it is too early to establish such a causal connection without more detailed study of patients with these conditions and similar gene mutations. This work was supported by the National Health and Medical Research Council of Australia.
 
Professor Ingrid Scheffer will be organizing a symposium on "Advances in Genetics on Focal Epilepsies" at the 13th International Child Neurology Congress to held at Iguazu Falls, Brasil May 4-9 2014.
 
Citation:
 
1.Dibbens LM, de Vries B, Donatello S, Heron SE, Hodgson BL, Chintawar S, Crompton DE, Hughes JN, Bellows ST, Klein KM, Callenbach PM, Corbett MA, Gardner AE, Kivity S, Iona X, Regan BM, Weller CM, Crimmins D, O'Brien TJ, Guerrero-López R, Mulley JC, Dubeau F, Licchetta L, Bisulli F, Cossette P, Thomas PQ, Gecz J, Serratosa J, Brouwer OF, Andermann F, Andermann E, van den Maagdenberg AM, Pandolfo M, Berkovic SF, Scheffer IE. Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet. 2013 Mar 31. doi: 10.1038/ng.2599. [Epub ahead of print] PubMed PMID: 23542697.
 

Read More

Details
News
Hits: 2207
Symposia Proposal Chair Country
Focal Epilepsies- Advances in Genetics Ingrid Scheffer Australia
Genetics in Infantile Epileptic Encephalopathy Kim Heung Dong South Korea
The Clinical Context of Autoimmune Neuropsychiatric Disorders Hila Ben-Pazi Israel
Inherited Leukoencephalopathies Deborah Renaud USA
Pediatric Demyelinating Disorders and MS Evangeline Wasssmer UK
Cerebral Palsy Pratibha Singhi India
Neurometabolic Disorders-Treatment Update Ingrid Tein Canada
Improving outcomes in childhood epilepsyLieven Lagae Helen Cross Belgium UK
Brain Stimulation in Children; Neurophysiology and Therapeutics Adam Kirton Canada
Frontiers in Neuroprotection of the Neonatal Brain Rand Askalan Canada
Acute Leukoencephalopathies in Children Silvia Tenembaum Argentina
Neuroinflammation Leonardo de Azevado Brazil
Childhood Headaches - Current treatment and Research Kenneth Mack USA
Update on Neuroimaging Harry Chugani USA
Update on Neuromuscular Diseases Rosalin Quinlivan UK

Details
News
Hits: 521

The ICNC2014 Scientific Program Committee is delighted to announce the Plenary Speakers for the ICNC2014 to held at Iguazu Falls, Brasil from May 4-9, 2014. All world leaders in their field and engaging speakers, the plenary lecturers will be addressing a range of emerging and cross-cutting topics in pediatric neurology.

The list and titles of plenary talks are as follows:

Dealing with the Coming Tsunami of Whole Genome Sequencing

Arnold Munnich, INSERMProf. Arnold Munnich
Director
Institut National de la Santé et de la Recherche Médicale (INSERM)
France

Professor Arnold MunnichSince 1980, Professor Arnold Munnich has made every efforts to conciliate the clinical and molecular approaches of genetic diseases in children. His efforts have resulted in the founding of the Department of Genetics, Hôpital des Enfants-Malades, Paris, which brings together i) a Clinical Research INSERM unit, dedicated to the mapping and identification of genes causing developmental and neurogenetic diseases in children, ii) the Medical Genetic Clinic of Assistance Publique, Hôpitaux de Paris. Prof Munnich has mapped and/or identified twenty disease causing genes, including the genes for:
  • achondroplasia (1/15,000 live births, fibroblast growth factor receptor 3)
  • Hirschsprung disease (1/5,000 live births, Ret oncogene)
  • spinal muscular atrophy (1/6,000 live births, survival motor neuron, SMN)
  • X-linked spastic paraplegia (proteolipid protein)
  • Holt-Oram syndrome (brachyury), - multiple exostosis (EXT)
  • Stargardt macular dystrophy (ABCR4)
  • Leber congenital amaurosis (retinal guanylate cyclase)
  • Saethre-Chotzen craniosynostosis (twist)
  • Pearson’s marrow pancreas syndrome (mitochondrial DNA deletion)
  • the first nuclear gene for Leigh syndrome (SDH, FP)
  • mental retardation (AR) : neurotrypsine
  • several nuclear genes for mitochondrial diseases (BCS1, COX10, SCO1)
  • Triple A syndrome (1/50,000 live births, Aladin)
  • Incontinentia pigmenti (1/5,000 live births, Nemo, with the International IP Consortium) and ectodermal dysplasia-immune deficiency (1/5,000 live births, Nemo and Iκ Bα).
He has recently shown that Friedreich ataxia results from multiple iron-sulphur protein injury caused by iron overload in mitochondria. Based on this observation, he devised a novel therapeutic approach using short-chain quinones (Idebenone) to protect iron sulphur centers from oxidative stress. This treatment, now given to all novel cases, cures cardiomyopathy in 85% of patients. He has also identified a novel inborn error of quinone synthesis resulting in multiple respiratory chain deficiency and caused by a point mutation in a polyprenyl transferase gene. Most importantly, children are cured by oral quinone administration.

[Back to TOP]

Lessening the Burden of Neurological Disorders in Low Resource Settings; A Ground Level Perspective

Naila Khan-tProfessor Naila Zaman Khan
Bangladesh Institute of Child Health

 

Professor Naila Zaman KhanProfessor Naila Zaman Khan is the head of the Department of Pediatric Neurosciences at Dhaka Shishu (Children’s) Hospital and academic director of Bangladesh Institute of Child Health. The Child Development Centre & Neurology Unit,at the Dhaka Shishu (Children) Hospital the first of its kind with in an acute care hospital in Bangladesh was established in 1992 by Professor Naila Zaman Khan. It includes an out-patients clinic, an in-patients neurology ward& a multidisciplinary Child Development Centre or CDC (Shishu Bikash Kendro in Bangla). Specialized clinics within the CDC include a General Developmental Assessment Clinic, Epilepsy Clinic, Speech Language and Communication Clinic, Low Vision Clinic, Seating and Feeding Clinic, Mental Health Services, Psychological Assessment, Psychosocial Counseling Clinic, More Than Words Clinic (for children with Autism Spectrum Disorders), and a Well Baby Clinic (for at-risk children especially newborns and neonates),

A multidisciplinary team of professionals comprising of physicians, psychologists, developmental therapists, neurophysiologists and psychosocial counselors provide key services to the children and families within the CDC, which aims to improve functional skills and adaptive behavior of the children presenting with a range of acute and chronic neurodevelopmental delays and disorders. Based upon the success of the CDC, and with the assistance of DSH, the Ministry of Health and Family Welfare, Government of Bangladesh, has starting replicating similar Shishu Bikash Kendras across all medical college hospitals of the country.

[Back to TOP]

The New Technologies in Neurorehabilitation

Tamar Weiss-tProfessor Patrice (Tamar) Weiss
Head of the Laboratory for Innovations in Rehabilitation Technology
University of Haifa, Israel

 

Professor Patrice L. (Tamar) WeissProfessor Patrice Weiss is the Head of the Laboratory for Innovations in Rehabilitation Technology at the University of Haifa, Israel. The Laboratory for Innovations in Rehabilitation Technology (LIRT) was founded at the University of Haifa (Haifa, Israel) in 2001 by Prof. Patrice L. (Tamar) Weiss. LIRT's focus is on the development and evaluation of novel virtual environments, computer interfaces, and co-located technologies to explore their effect on body functions (e.g. motor and cognitive abilities), activities (e.g. meal preparation) and participation in community life. Rehabilitation populations of interest include spinal cord injury, stroke, cerebral palsy, developmental coordination disorder, autism and head trauma.

Prof. Weiss is a founding board member of the International Society of Virtual Rehabilitation. She has authored more than 120 peer-reviewed journal articles and book chapters. For the past five years she has joined forces with a team of researchers from Italy and the UK to enhance social interaction through story-telling and collaborative games among high-functioning children with autism. Funded by the European Union FP7 ICT program, novel collaborative virtual environments and collocated table-top technologies have been demonstrated to significantly improve the social interaction skills of children with autism. Together with Italian and Israeli collaborators, she has developed a novel collocated technology to facilitate conflict escalation and de-escalation between Israeli-Jewish and Palestinian-Arab youth wherein face-to-face, tangible individual contributions were combined with joint actions. Funded by the Israeli Science Foundation, the results of an extended evaluation show a significant shift to a more positive attitude toward a peer from another culture due to enhanced visibility of the conflict, and the notion that increased awareness enables a participant to deal with a dyadic cycle of conflict related actions and reactions.

[Back to TOP]

What Can We Reasonably Expect from Stem Cell Therapy-Beyond the Hype and the Hope

mackay-sim-tProfessor Alan Mackay-Sim
Griffith University, Queensland, Australia

 

Professor Alan Mackay-SimProfessor Mackay-Sim has had along interest in regeneration and repair of the nervous system. For many years his passion has been to understand the regeneration and repair of the olfactory mucosa, the organ of the sense of smell in the nose, in which new sensory nerve cells are made throughout adult life. This is a fascinating biological question that has many direct applications to understanding human disease and repairing other parts of the nervous system. Olfactory tissue is easily accessible and provides the scientist and clinician with neural cells and the adult stem cells that give rise to them. In essence the nose provides a "window into the brain" to study cellular processes of disease and also provides adult neural stem cells with the potential to repair the nervous system. Professor Mackay-Sim and his research team are using olfactory stem cells to develop cellular models of diseases such as schizophrenia, Parkinson’s disease and motor neurone disease. They have already identified differences in nerve cell regeneration in schizophrenia and bipolar disorder that help understand how these diseases develop. Professor Mackay-Sim is scientific director of a clinical trial in which cells from the nose (called "olfactory ensheathing cells") are taken from the nose of people with paraplegia after traumatic spinal cord injury, grown in the lab, and transplanted into their own injured spinal cord. This trial provides a precedent for future trials using adult stem cells.

[Back to TOP]

Fetal Neurology; An Emerging Subspecialty?

DuPlessis A-tProfessor Adré Jacques du Plessis
Children's National Medical Center, Washington, DC

 

Professor Adré Jacques du PlessisProfessor Adré Jacques du Plessis is the Chief of Fetal and Transitional Medicine at Children’s National Medical Center and Professor of Pediatrics at George Washington University School of Medicine and Health Sciences. He was previously the Director of Fetal and Neonatal Neurology at Children’s Hospital of Boston, and Associate Professor of Neurology at Harvard Medical School. He developed and directed the first pediatric program dedicated to neurocritical care, as well as the largest program in fetal-neonatal neurology at Children’s Hospital in Boston. His research and clinical activities are focused on mechanisms of injury to the immature brain in high risk populations including the fetus and infant with congenital heart disease, infants born prematurely, and infants exposed to perinatal asphyxia.

He has developed techniques for evaluating continuous cerebral blood flow and metabolism at the bedside of high-risk infants using primarily near infrared spectroscopy. He has received NIH funding for his research since 1994 and has mentored trainees from multiple disciplines with philanthropic and more recently NIH (K24) support. A number of these trainees have achieved independent research funding and leadership positions in large academic centers around the world.

[Back to TOP]


Read More
  1. MSc Course in Epilepsy (Institute of Psychiatry, King's College London)
  2. Welcome to Brazil for the 13th International Child Neurology Congress ICNC2014
  3. Welcome to Brazil for the 13th International Child Neurology Congress ICNC2014
  4. Thankyou for supporting the ICNA

Page 40 of 64

Join Our Newsletter

Log in

X